Steven A Greenberg

Steven A. Greenberg, M.D., M.S. is a founder of Abcuro and is the Chief Scientific Advisor. Steven is a clinical neurologist at Brigham and Women’s Hospital and a Professor of Neurology at Harvard Medical School. His clinical and laboratory research focus involves translational medicine, inventing diagnostics including blood tests for dermatomyositis and inclusion body myositis, and therapeutics, including co-inventing a therapeutic monoclonal antibody for dermatomyositis currently in phase 2 studies. He has authored over 100 publications and served as Principal Investigator for multiple clinical trials, and is the founder of the non-profit research organization, the Inclusion Body Myositis Foundation. Steven received an A.B. degree in Mathematics from Princeton University, an M.S. degree in Medical Informatics from MIT, and an M.D. degree from Harvard Medical School through the Harvard-MIT Health Science and Technology Program.